Italy · Delayed Price · Currency is EUR Silk Road Medical Statistics
Total Valuation
Abitare In has a market cap or net worth of EUR 72.52 million. The enterprise value is 66.86 million.
| Market Cap | 72.52M |
| Enterprise Value | 66.86M |
Important Dates
The last earnings date was Thursday, August 7, 2025.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Abitare In has 25.54 million shares outstanding. The number of shares has increased by 5.21% in one year.
| Current Share Class | 25.54M |
| Shares Outstanding | 25.54M |
| Shares Change (YoY) | +5.21% |
| Shares Change (QoQ) | +63.47% |
| Owned by Insiders (%) | 53.03% |
| Owned by Institutions (%) | 9.72% |
| Float | 11.99M |
Valuation Ratios
The trailing PE ratio is 20.84 and the forward PE ratio is 6.33.
| PE Ratio | 20.84 |
| Forward PE | 6.33 |
| PS Ratio | 1.75 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 0.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.35, with an EV/FCF ratio of -1.40.
| EV / Earnings | 16.84 |
| EV / Sales | 1.62 |
| EV / EBITDA | 4.35 |
| EV / EBIT | 4.55 |
| EV / FCF | -1.40 |
Financial Position
The company has a current ratio of 3.12
| Current Ratio | 3.12 |
| Quick Ratio | 0.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 2.11 |
Financial Efficiency
Return on equity (ROE) is 3.49% and return on invested capital (ROIC) is 5.61%.
| Return on Equity (ROE) | 3.49% |
| Return on Assets (ROA) | 2.78% |
| Return on Invested Capital (ROIC) | 5.61% |
| Return on Capital Employed (ROCE) | 5.50% |
| Revenue Per Employee | 752,327 |
| Profits Per Employee | 72,204 |
| Employee Count | 54 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 0.07 |
Taxes
In the past 12 months, Abitare In has paid 2.21 million in taxes.
| Income Tax | 2.21M |
| Effective Tax Rate | 36.49% |
Stock Price Statistics
The stock price has decreased by -34.71% in the last 52 weeks. The beta is 0.64, so Abitare In's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -34.71% |
| 50-Day Moving Average | 3.13 |
| 200-Day Moving Average | 3.64 |
| Relative Strength Index (RSI) | 37.38 |
| Average Volume (20 Days) | 25,023 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Abitare In had revenue of EUR 41.38 million and earned 3.97 million in profits. Earnings per share was 0.14.
| Revenue | 41.38M |
| Gross Profit | 24.65M |
| Operating Income | 14.68M |
| Pretax Income | 6.05M |
| Net Income | 3.97M |
| EBITDA | 15.39M |
| EBIT | 14.68M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 9.13 million in cash and n/a in debt, giving a net cash position of 9.13 million or 0.36 per share.
| Cash & Cash Equivalents | 9.13M |
| Total Debt | n/a |
| Net Cash | 9.13M |
| Net Cash Per Share | 0.36 |
| Equity (Book Value) | 111.95M |
| Book Value Per Share | 2.62 |
| Working Capital | 207.53M |
Cash Flow
In the last 12 months, operating cash flow was -47.44 million and capital expenditures -312,997, giving a free cash flow of -47.76 million.
| Operating Cash Flow | -47.44M |
| Capital Expenditures | -312,997 |
| Free Cash Flow | -47.76M |
| FCF Per Share | -1.87 |
Margins
Gross margin is 59.56%, with operating and profit margins of 35.48% and 9.60%.
| Gross Margin | 59.56% |
| Operating Margin | 35.48% |
| Pretax Margin | 14.61% |
| Profit Margin | 9.60% |
| EBITDA Margin | 37.19% |
| EBIT Margin | 35.48% |
| FCF Margin | n/a |
Dividends & Yields
Abitare In does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.21% |
| Shareholder Yield | n/a |
| Earnings Yield | 5.48% |
| FCF Yield | -65.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 21, 2021. It was a forward split with a ratio of 10.
| Last Split Date | Jun 21, 2021 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |